version 3.4.4 (R Foundation for Statistical Computing). Univariate and multivariable regression were performed using SAS 9.4 (SAS Institute Inc) to evaluate the associations between clinical characteristics and anemia prevalence, evaluation, and treatment
Search Results
Demetra Hypatia Hufnagel, Sumit Tushar Mehta, Chinyere Ezekwe, Alaina J. Brown, Alicia Beeghly-Fadiel, and Lauren Shore Prescott
Apostolia M. Tsimberidou, Alexandra M. Adamopoulos, Yang Ye, Sarina Piha-Paul, Filip Janku, Siqing Fu, David Hong, Gerald S. Falchook, Aung Naing, Jennifer Wheler, Adoneca Fortier, Razelle Kurzrock, and Kenneth R. Hess
date of last follow-up were censored on that date. The patient characteristics were analyzed using descriptive statistics. Survival functions were estimated using the Kaplan-Meier method. Results Demographics From July 2010 to December
Guru Subramanian Guru Murthy, Aniko Szabo, Laura Michaelis, Karen-Sue Carlson, Lyndsey Runaas, Sameem Abedin, and Ehab Atallah
characteristics, type of malignancy, and survival duration; however, it did not provide information on patient symptoms, performance status, cytogenetics, MRD, treatment drugs, stem cell transplantation, or other prognostic factors. Selection criteria for this
Eric J. Roeland, Daniel P. Triplett, Rayna K. Matsuno, Isabel J. Boero, Lindsay Hwang, Heidi N. Yeung, Loren Mell, and James D. Murphy
after cancer diagnosis. Regional Covariates This study evaluated the association between the regional use of cancer-related palliative care and regional health care characteristics. Regional geography was evaluated at the level of hospital
Andrew Trunk, Matthew Braithwaite, Christopher Nevala-Plagemann, Lisa Pappas, Benjamin Haaland, and Ignacio Garrido-Laguna
molecular biology and genomic profiling have led to the identification of several genetic aberrations and tumor characteristics that allow for distinct subgroups of metastatic CRC (mCRC) with both prognostic and predictive implications. One of these
Cary P. Gross, Craig S. Meyer, Sarika Ogale, Matthew Kent, and William B. Wong
first evidence of treatment ≥4 months from their advanced diagnosis date. Patient attrition is shown in supplemental eTable 1 (available with this article at JNCCN.org ). Construction of Variables Clinical characteristics included demographics
Jamie M. Jacobs, Molly E. Ream, Nicole Pensak, Lauren E. Nisotel, Joel N. Fishbein, James J. MacDonald, Joanne Buzaglo, Inga T. Lennes, Steven A. Safren, William F. Pirl, Jennifer S. Temel, and Joseph A. Greer
. Research staff collected information about cancer diagnosis, oral therapy type, and other clinical characteristics from the EHR. Electronic Adherence Monitoring Participants were asked to store their oral therapy medication in pill bottles with electronic
Arif H. Kamal, Steve Power, Gloria Broadwater, Audrey R. Holland, and Paul K. Marcom
with patient characteristics, these profiles ensure that targeted therapies are selectively applied in delivering patient-centered care. A shining example of this has been the incorporation of trastuzumab for cancers that overexpress HER2, the use of
Joyce Valerie Veld, Femke Julie Amelung, Wernard Aat Antoine Borstlap, Emo Eise van Halsema, Esther Catharina Josephina Consten, Peter Derk Siersema, Frank ter Borg, Edwin Silvester van der Zaag, Paul Fockens, Willem Adrianus Bemelman, Jeanin Elise van Hooft, Pieter Job Tanis, and for the Dutch Snapshot Research Group
, potential eligible patients were first identified through the DCRA, and collaborators in each participating hospital were provided with their own patients registered in the DCRA. Subsequently, collaborators extended baseline characteristics and short
Lara Franziska Stolzenbach, Giuseppe Rosiello, Angela Pecoraro, Carlotta Palumbo, Stefano Luzzago, Marina Deuker, Zhe Tian, Anne-Sophie Knipper, Raisa Pompe, Kevin C. Zorn, Shahrokh F. Shariat, Felix K.H. Chun, Markus Graefen, Fred Saad, and Pierre I. Karakiewicz
version 3.4.1 (R Foundation for Statistical Computing). All tests were 2-sided with a level of significance set at P <.05. Results Descriptive Characteristics Of all 210,100 patients treated with RP, 4,704 (2.2%), 17,785 (8.4%), and 11,040 (5
